June 30, 2020 Price forecast | 2 weeks: -2.96% | 1 month: -5.86% | 3 months: -7.99%


TBIO stock forecast

Our latest prediction for Translate Bio, Inc.'s stock price was made on the June 30, 2020 when the stock price was at 17.92$.

In the short term (2weeks), TBIO's stock price should underperform the market by -2.96%. During that period the price should oscillate between -12.56% and +11.44%.

In the medium term (3months), TBIO's stock price should underperform the market by -7.99%. During that period the price should oscillate between -40.74% and +26.45%.

Create a solid portfolio with TBIO

Add TBIO to your portfolio and optimize it!


About Translate Bio, Inc.

Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidates include MRT5005 for the treatment of cystic fibrosis; and for the treatment of ornithine transcarbamylase deficiency. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA.

At the moment the company generates 11M USD in revenues.

On its last earning announcement, the company reported a loss of -1.70$ per share.

The book value per share is 2.27$

Translate Bio, Inc. website


Three months stock forecastJune 30, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
11M - -99M -900.70% -94M -1.70 - - 55M 2.27 -92M -5M -97M